account_id none on file
legal_name Aura Biosciences, Inc.
ticker AURA
cik 1501796
domain aurabiosciences.com
linkedin_company_url https://www.linkedin.com/company/aurabiosciences/
entry_point_account_id none on file
name Aura Biosciences Inc.
exchange Nasdaq
sector Health Care
hq Boston, MA, United States
sector index/company/sector/health-care/
calls 0 filings 6 executives 2 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include professional fees for legal, accounting, auditing, tax and consulting services; travel expenses; and facility-related expenses, which include allocated expenses for rent and maintenance of facilities and other operating costs not included in research and development.
filing / Aug 11, 2026 / receipt
In August 2026, our Board of Directors approved a plan to streamline our operating plan and organizational structure to focus resources in ocular oncology, including a reduction in force of approximately 20% of our workforce.
filing / Aug 11, 2026 / receipt
Moreover, in August 2026, we approved a plan to streamline our operating plan and organizational structure to focus resources in ocular oncology, including a reduction in force of approximately 20% of our workforce.
filing / Aug 11, 2026 / receipt
The increased costs may require us to reduce costs in other areas of our business or increase the prices of our products once commercialized.
filing / Aug 11, 2026 / receipt
healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications.
filing / Aug 11, 2026 / receipt
Further, as a result of increased hybrid work, a significant number of our employees and partners are working remotely, which increases the risk of a cybersecurity incident or data breach or other data and cybersecurity issues.
filing / Aug 11, 2026 / receipt
executives
| Anthony Gibney | Chief Financial and Business Officer | receipt | |
| Natalie Holles | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2026-05-04 | Chief Executive Officer, appointed | sec_8k |
| 2025-05-15 | Chief Financial and Business Officer, appointed | sec_8k |
mcp_package_hint
slug aura-biosciences-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$